CIK 0001061983 · Large accelerated filer
CYTOKINETICS INC
Sign in to watch- Ticker
- CYTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 943291317
- Phone
- (650) 624-3000
- Business address
- 350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,208,275
- in 16 filings, $12.2M under 10b5-1 plans
Net −$12,208,275. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-07 | Malik Fady Ibraham EVP Research & Development | Option exercise · Non-Qualified Stock Option (Right to Buy) 10b5-1 | −1,000 | 0 | ||
| 2026-04-01 | Blum Robert I President & CEO | Sale 10b5-1 | −7,500 | $66.63 | $500K | 422,830 |
| 2026-03-31 | Callos Andrew EVP, Chief Commercial Officer | Sale 10b5-1 | −3,639 | $65.00 | $237K | 66,004 |
| 2026-03-18 | Callos Andrew EVP, Chief Commercial Officer | Sale 10b5-1 | −1,930 | $62.07 | $120K | 78,185 |
| 2026-03-17 | Lee Sung EVP, Chief Financial Officer | Sale | −4,935 | $62.15 | $307K | 87,127 |
| 2026-03-17 | Callos Andrew EVP, Chief Commercial Officer | Sale | −5,626 | $62.15 | $350K | 74,489 |
| 2026-03-17 | Callos Andrew EVP, Chief Commercial Officer | Sale | −2,916 | $62.15 | $181K | 71,573 |
| 2026-03-17 | Malik Fady Ibraham EVP Research & Development | Sale | −7,636 | $62.15 | $475K | 158,299 |
| 2026-03-17 | Malik Fady Ibraham EVP Research & Development | Sale | −4,397 | $62.15 | $273K | 153,902 |
| 2026-03-17 | Blum Robert I President & CEO | Sale | −12,673 | $62.15 | $788K | 454,258 |
| 2026-03-17 | Blum Robert I President & CEO | Sale | −23,928 | $62.15 | $1.5M | 430,330 |
| 2026-03-16 | Callos Andrew EVP, Chief Commercial Officer | Sale 10b5-1 | −1,709 | $61.03 | $104K | 46,149 |
| 2026-03-15 | Blum Robert I President & CEO | Grant or award | +75,258 | 466,931 | ||
| 2026-03-15 | Blum Robert I President & CEO | Grant or award · Incentive Stock Option (Right to Buy) | +1,665 | 1,665 | ||
| 2026-03-15 | Blum Robert I President & CEO | Grant or award · Non-Qualified Stock Option (Right to Buy) | +111,864 | 111,864 | ||
| 2026-03-15 | Callos Andrew EVP, Chief Commercial Officer | Grant or award | +20,646 | 68,504 | ||
| 2026-03-15 | Callos Andrew EVP, Chief Commercial Officer | Grant or award | +13,320 | 81,824 | ||
| 2026-03-15 | Callos Andrew EVP, Chief Commercial Officer | Grant or award · Incentive Stock Option (Right to Buy) | +1,665 | 1,665 | ||
| 2026-03-15 | Callos Andrew EVP, Chief Commercial Officer | Grant or award · Non-Qualified Stock Option (Right to Buy) | +29,480 | 29,480 | ||
| 2026-03-15 | Hessekiel Jeffrey Chief Legal & Admin Officer | Grant or award | +20,646 | 107,943 |
Page 10 of 22 · 429 trades